Shock

Updated: August 6, 2024

Mail Whatsapp PDF Image

Background

Shock is a life-threatening condition resulting from inadequate circulatory capacity; this consequently results in poor tissue perfusion and oxygenation. This leads to blocking cellular functions and in turn damages the organs of the human body. In the early stages, shock may be completely counteracted, but if there is a delay in diagnosis or treatment, it may evolve to the status of irreversible damage and lead to multiorgan failure and death. 

Epidemiology

Based on the cause, distributive shock is the most common type of shock, while hypovolemic and cardiogenic shocks are less common. Obstructive shock is rarer. The most common distributive shock is the septic shock; this type of shock has a high mortality index of 40-50%. 

Anatomy

Pathophysiology

Cellular hypoxia initiates metabolic and biochemical modifications resulting into acidosis and low regional blood flow that worsens territorial hypoxia. Hypovolemic, obstructive, and cardiogenic shock are associated with reduced cardiac output and oxygen delivery, while distributive shock is defined by decreased peripheral resistance and impaired tissue oxygen utilization. Shock goes through a number of physiological steps, which are reversible in the initial stages and final stages are irreversible, which may lead to multiple organ dysfunction and mortality.

The three stages of shock are: 

  • Pre-shock or Compensated Shock: The body initiates autoregulation processes to ensure tissue perfusion and includes tachycardia, peripheral vasoconstriction, and variations in systemic blood pressure. 
  • Shock: Clinical features that define shock then become manifest when early multiple organ dysfunction syndromes occur in the case of failure of compensation. 
  •  
  • End-Organ Dysfunction: This is the final stage where the organ damage becomes fatal, and this results in multi organ failure and death. 

Etiology

It is a clinical condition in which there is either tissue hypoxia because of low oxygen delivery or high oxygen demand in tissues. This potentially fatal circulatory dysfunction is characterized by hypotension, with systolic blood pressure below 90 mm Hg, or Mean arterial pressure below 65 mm Hg. It may be caused by many factors and may lead to death if left untreated. It is classified into four main types: are distributive, hypovolemic, cardiogenic, and obstructive. 

Types of Shock: 

  • Distributive Shock: A condition marked by the dilation of blood vessels, which leads to the reduction of pressure in the circulatory system. Subtypes include: 
  • Septic Shock: Due to a serious infection that resulted in organ compromise and an abnormal immune response and involving the use of vasopressors. 
  • Systemic Inflammatory Response Syndrome (SIRS): Bacterial (such as, bacteria and fungi), non-bacterial (for example, pancreatic and burn). 
  • Anaphylactic Shock: Anaphylaxis manifested by cardiovascular compromise and acute hypoxic respiratory failure. 
  • Neurogenic Shock: Secondary to brain or spinal cord injury where the balance of the autonomic nervous system is disturbed. 
  • Endocrine Shock: As a result of certain diseases like adrenal insufficiency etc. 
  • Hypovolemic Shock: Resulting from decrease in intravascular volume, which results in hypotension. Subtypes include: 
  • Hemorrhagic: As a result of other disorders that include gastrointestinal bleeding, traumatic bleeding, or vascular diseases. 
  • Non-Hemorrhagic: As a result of vomiting, diarrhea, kidney infections, burn, or other illnesses such as pancreatitis among others. 
  • Cardiogenic Shock: Resulting from heart related complications; that lowers cardiac output, including: 
  • Cardiomyopathies: For instance, it may be caused by conditions such as acute myocardial infarction or myocarditis. 
  • Arrhythmias: It can lead to both tachyarrhythmias and bradyarrhythmias. 
  • Mechanical Complications: Critically compromised valve function or apparatus failure, such as myocardial rupture. 
  • Obstructive Shock: Pump dysfunction associated with factors outside the heart that impair the ability of ventricles to deliver adequate amounts of blood: 
  • Pulmonary Vascular Causes: Disorders of blood circulation such as pulmonary embolism or severe hypertension. 
  • Mechanical Causes: Conditions that affect the ability of the heart to fill with blood or venous return such as tension pneumothorax or pericardial tamponade. 

Genetics

Prognostic Factors

Sepsis and septic shock are associated with both short and long-term combined mortalities, and many survivors require further care in long-term acute care hospitals or post-acute care facilities. The mortality of the septic shock stands at a shocking 40 to 50 percent. Cardiogenic shock has a relatively higher mortality ratio estimated at 50-75% although this has been observed to be lowering gradually in the recent past. Hypovolemic and obstructive shock on the other hand, often come with relatively lower mortality rates, and are usually more sensitive to treatment measures. 

Clinical History

Distributive Shock: 

  • Age Group: All ages. 
  • Associated Comorbidities/Activities: Bacterial and viral, inhaled allergens, physical and chemical injury, glandular imbalance. 
  • Acuity: Dramatic; often gets worse quickly. 

Hypovolemic Shock: 

  • Age Group: All populations; however, children and the elderly are at higher risk. 
  • Associated Comorbidities/Activities: Hemorrhagic shock, traumatic shock, septic shock and hemorrhagic shock including paralysis of the gut, blood vomiting. 
  • Acuity: Mild: acute, occurs after massive loss of fluid or blood. 

Cardiogenic Shock: 

  • Age Group: Although it is more frequently diagnosed in the elderly population, it is essential not to exclude alcohol consumption throughout their entire life. 
  • Associated Comorbidities/Activities: Heart diseases, Ischemic heart diseases, Acute coronary syndromes, Myocardial infarction, Cardiac arrhythmias. 
  • Acuity: Sudden; the situation may change immediately in patients with cardiac issues. 

Obstructive Shock: 

  • Age Group: People of all ages including adults, adolescents and even children depending on the cause. 

Physical Examination

  • General Appearance: May look anxious, lethargic or confused; skin may be pale and sweaty (hypovolemic/cardiogenic or red and warm (distributive). 
  • Vital Signs: Systolic blood pressure ≤90 mm Hg or mean arterial pressure ≤65 mm Hg, tachycardia, and tachypnoea. 
  • Cardiovascular: He has slow rate, decreased heart tones, and elevated jugular venous pressure in obstructive shock or decreased in hypovolemic shock. 
  • Respiratory: Tachypnea; hypoxemia common, especially if patient has secondary pulmonary disease process. 
  • Abdominal: Presence of distention or reduced bowel movements and sounds. 

Age group

Associated comorbidity

These include pulmonary embolism, tension pneumothorax, pericardial tamponade.

Associated activity

Acuity of presentation

Sharp; occurs abruptly because of blockages or problems with the pressure. 

Differential Diagnoses

  • Hypovolemic shock 
  • Cardiogenic shock 
  • Disruptive shock 
  • Septic shock 
  • Anaphylactic shock 
  • Neurogenic shock 
  • Endocrine shock 
  • Obstructive shock 
  • Pulmonary vascular causes 
  • Mechanical causes 

Laboratory Studies

Imaging Studies

Procedures

Histologic Findings

Staging

Treatment Paradigm

General Principles: Determine the type of shock and its source based on the patient’s history, examination, and further testing. ABC’s should be checked and secured. 

Fluid Resuscitation: Give intravenous fluid therapy (for example isotonic fluids such as normal saline or Ringer’s lactate) to replenish intravascular volume and enhance tissue perfusion. The patient should also have their fluid levels checked constantly and periodically changed depending on their reaction to the new fluid levels and presence of clinical signs of fluid overload. 

Vasopressor and Inotropic Support: They are used to raise blood pressure and optimize blood flow to tissues (e. g. norepinephrine, vasopressin, epinephrine). Enhance myocardial contractility in conditions of cardiogenic shock (for example, dobutamine, milrinone). 

Addressing the Underlying Cause 

  • Infectious Shock (Septic Shock): Give broad-spectrum antibiotics and manage the source of the infection (such as draining abscesses). 
  • Hypovolemic Shock: Decrease the amount of fluid that leaks from the system (for example, stop blood loss by performing surgery). 
  • Cardiogenic Shock: Manage the underlying cardiovascular disease (for example, percutaneous coronary intervention for acute myocardial infarction, anti-arrhythmic therapy for arrhythmias). 
  • Obstructive Shock: Treat the cause of the obstruction (e.g. needle thoracocentesis for tension pneumothorax, pericardiocentesis for pericardial tamponade). 

Supportive Therapies 

  • Oxygen Therapy: This will enhance oxygenation in the body as well as reduce arterial hypoxia. 
  • Nutritional Support: Make sure that the patient is fed well, particularly if he or she is in a state of shock for many hours or days. 
  • Monitoring and Reassessment: Monitor cardiovascular and pulmonary status, laboratory values, including arterial blood gases, urine output, and other parameters of perfusion and response to treatment. Always assess the progress of interventions and modify the applied therapy plan accordingly. 

by Stage

by Modality

Chemotherapy

Radiation Therapy

Surgical Interventions

Hormone Therapy

Immunotherapy

Hyperthermia

Photodynamic Therapy

Stem Cell Transplant

Targeted Therapy

Palliative Care

use-of-a-non-pharmacological-approach-for-treating-shock

  • Fluid Resuscitation: Give isotonic solution such as normal saline or Ringer’s lactate to help replenishing the blood volume and influx blood flow. To prevent overhydration, monitor the fluid balance of the patient. 
  • Positioning: At times, elevation of legs (Trendelenburg position) facilitates the venous return to the heart; however, this technique is not employed much now because of the inconclusive data on its effectiveness. 
  • Oxygenation: Administer high concentration oxygen to raise the tissue oxygen level and minimize hypoxemia and tissue hypoxia. 
  • Temperature Regulation: When managing hypovolemic or septic shock, use blankets or warming equipment to keep the patient’s temperature warm so that his or her blood vessels circulate well. 
  • Nutritional Support: Super adequate nutritional support through enteral feeding or parenteral nutrition especially in conditions of situs of severe shock. 

Role of Isotonic Crystalloids

  • Normal Saline (0.9% Sodium Chloride): It has sodium at a level of 154 milliequivalents per litre and chloride at a level of also 154 milliequivalents per litre. It is frequently given at the start of hypovolemic and septic shock patients’ resuscitation. It is effective for replenishing the volume and for preservation of blood pressure and possibly, if administered in large volumes or for extended periods, it may cause hyperchloremic metabolic acidosis. 
  • Lactated Ringer’s Solution (LR): It consists of sodium, chloride, potassium, calcium, and lactate. It is transported to the liver where the lactate is converted to bicarbonate to reduce possible acidosis. This tends to be used in most cases of hypovolemic shock particularly in surgeries and trauma cases. This involves providing electrolyte and aid in the elimination of acidosis. 

Role of Vasopressors

  • Dobutamine: Initial inotropic drug of choice used in cardiogenic shock and severe heart failure. This drug predominantly exhibits its effect on beta-1 adrenergic receptors hence promoting enhanced force of contractions and rate of heart beats. It has a comparatively notable beta-2 adrenergic actions that result in peripheral vasodilatation. It is useful in enhancing cardiac output in situations where there is reduced myocardial contractility such an acute left heart failure and cardiogenic shock. 
  • Dopamine: It is utilised in cardiogenic shock particularly when there is hypotension associated with reduced tissue perfusion. In cases where doses differ, it resembles the aspect of shock such as hypotension, and optionally, low cardiac output. 
  • Milrinone: It is given in those patients who present with cardiogenic shock especially when there is acute decompensated heart failure. A phosphodiesterase-3 inhibitor that raises intracellular cAMP thereby improving cardiac contractility and dilating the blood vessels. 

Role of Antibiotics

  • Piperacillin-Tazobactam: A combination antibiotic, derived from the broad-spectrum penicillin group, specifically piperacillin and the beta-lactamase inhibitor called tazobactam. It offers general antibacterial activity against various bacterial species, including both the gram-positive and the gram-negative class. It is used often in the initial empirical therapy in septic shock to include a range of pathogens that may be causing the syndrome. It is used when the causative bacteria are not known and but there is requirement of wide spectrum coverage.  
  • Vancomycin: It is a glycopeptide antibiotic with high bactericidal activity against Gram-positive bacteria, particularly against methicillin-resistant Staphylococcus aureus (MRSA). This class of antibiotics is particularly effective against Gram-positive bacteria, particularly various strains that are resistant to other drugs such as Methicillin-Resistant Staphylococcus aureus (MRSA). It is commonly prescribed in the situations, where either MRSA or other resistant Gram-positive bacteria are known to be present. 

use-of-intervention-with-a-procedure-in-treating-shock

Fluid Resuscitation: In shock, especially hypovolemic shock, the general management strategy involves the administration of fluids through a vascular access route. Crystalloids such as normal saline, lactated Ringer’s solution are often employed while colloids like hydroxyethyl starch may be administered in certain situations. 

Vasopressor Therapy: For instance, there is utilization of drugs such as Norepinephrine, Epinephrine, and dopamine to help raising blood pressure and hence enhance perfusion. These are particularly relevant in septic shock or cardiogenic shocks where there is inadequate adequate fluid load. 

Inotropic Agents: The treatments for cardiogenic shock include drugs like dobutamine or milrinone to enhance the strength of heart contraction or cardiac output respectively. 

Central Venous Pressure Monitoring: 

  • Central Line Insertion: The placement of a central venous catheter enables easy determination of the central venous pressure and also serves as an access point for fluid and medication administration. This is helpful in managing the fluid administration and in the assessment of the patient’s hemodynamic state. 
  • Arterial Line Insertion: An arterial catheter can also enable constant blood pressure measurement and the possibility to obtain frequent blood gases. It is especially useful for the administration of massive shock. 
  • Endotracheal Intubation and Mechanical Ventilation: When shock is linked with respiratory failure or the compromised airway, endotracheal intubation and mechanical ventilation might be necessary because of impaired ventilation and oxygenation. 
  • Surgical Interventions: Surgical intervention is often required in cases of traumatic shock, intraabdominal hemorrhage, or major infection such as sepsis and may be aimed at managing the underlying cause of the shock, for example bleeding or abscess aspiration. 

use-of-phases-in-managing-shock

  • Initial Assessment and Stabilization: Perform a primary and secondary assessment to address the patient’s airway, breathing, circulation. Start the process of quick fluid replacement and give oxygen to the patient.
  • Fluid Resuscitation: Give crystalloids (and colloids as required) to maintain intravascular volume. Supervise response and adapt corresponding interventions of fluid therapy appropriately. 
  • Identifying and Treating the Cause: Identify the possible cause of shock like infection, hemorrhage and initiate suitable treatment like antibiotics, vasopressors respectively. 
  • Supportive Care and Monitoring: Give care to support organ function, check vital signs, and adjust the treatment plan if required.
  • Reassessment and Ongoing Management: It is necessary to evaluate the patient’s condition and effectiveness of the implemented therapy periodically. 

Medication

 

vasopressin 

Post-Cardiotomy Shock-
0.03 units/minute intravenously initially.
Titrate up to 0.005 unit/minute at an interval of 10-15 minutes, until the required blood pressure is achieved.

Septic Shock-
0.01 units/minute intravenously initially.
Titrate up to 0.005 unit/minute at an interval of 10-15 minutes, until the required blood pressure is achieved.

Note:
It is used to raise blood pressure in patients with vasodilatory shock (such as those who have had a cardiotomy or who have sepsis) who are still hypotensive despite receiving fluids and catecholamines.



dexamethasone 

1-6 mg/kg intravenously once, or
40 mg intravenously every 2-6 hours as required
Alternatively, 20 mg intravenously, later 3 mg/kg per day intravenously
Do not continue high dose treatment more than 48-72 hours



synthetic human angiotensin II 


Indicated for Shock
Initial dose: 20ng/Kg/min intravenously by constant infusion
Titration dose: Check the blood pressure levels and titrate every 5 minutes up to 15 ng/kg/min as needed to achieve the desired blood pressure levels. Should not exceed 80 ng/kg/min while the first 3 hours of the treatment
Maintenance dose: dose as low as 1.25 ng/kg/min. Should not exceed 40 ng/kg/min
After the improvement of the Shock condition, titrate downward every 5-15 minutes up to 15 ng/kg/min, depending upon blood pressure levels
Administration through the central venous line is generally recommended
Note:
It is indicated to enhance blood pressure levels in adults with septic or distributive shock



metaraminol 

Indicated for severe shock
Initially, 0.5-5 mg through direct injection, after infusion of 15-100 mg in 0.5 L of diluent



pentastarch 


Indicated for Plasma volume expander for hypovolaemic shock
10% preparation: The suggested dose range is 500 ml to 1000 ml. The maximum dose is 1500 ml in a day
6% preparation: The suggested dose range is 500 ml to 1000 ml. The maximum dose is 2500 ml in a day
Note:
Given as a solution of normal saline/other electrolytes. The rate of infusion based on the quantity of fluid lost and the degree of haemoconcentration



phenylephrine 


Indicated for Severe Hypotension or Shock
Intravenous bolus: 40-100 mcg every 1-2 minutes as needed. Should not exceed the total dose 200 mcg
Adjust the dosage depending on the blood pressure levels
Continuous intravenous infusion: If the blood pressure levels are less than the target levels, start a continuous intravenous infusion of 10-35 mcg/min. Should not exceed 200 mcg/min
Note:
Renal impairment
End-stage renal disease: Data of dose-response indicate enhanced responsiveness to the phenylephrine
Mild-moderate: Start at low dose of the recommended dose and thereafter adjust the dose depending on blood pressure levels
Hepatic impairment
Moderate-severe: Data of dose-response indicate diminished responsiveness to the phenylephrine



dopamine 

Indicated for treating heart problems and imbalances in shock caused by infections, injuries, septicemia, surgery, kidney issues, or heart failure

Continuous infusion:

Initial dose: 2-10 mcg/kg/min intravenously (IV)

Maintenance dose: 2-50 mcg/kg/min intravenously (IV)



polygeline 

A maximum of up to 2000ml intravenously Indications: It is also indicated in isolated organ perfusion as a carrier for the infusion of insulin. It is used to treat hypovolemic shock



 

norepinephrine 

0.05-0.1 mcg/kg/min Intravenous infusion; titrate to the effect; should not exceed more than 2 mcg/kg/min



phenylephrine 


Indicated for Severe Hypotension or Shock as off-label
Age >2 years
5-20 mcg/kg intravenously one time; then after 0.1-0.5 mcg/kg/min intravenously. Should not exceed 3-5 mcg/kg/min intravenously
Age <2 years
Safety and efficacy not established



levarterenol 

0.05 mcg/kg/min to 0.1 mcg/kg/min intravenous infusion

It should not exceed 2 mcg/kg/min



 

Media Gallary

Content loading

Latest Posts

Shock

Updated : August 6, 2024

Mail Whatsapp PDF Image



Shock is a life-threatening condition resulting from inadequate circulatory capacity; this consequently results in poor tissue perfusion and oxygenation. This leads to blocking cellular functions and in turn damages the organs of the human body. In the early stages, shock may be completely counteracted, but if there is a delay in diagnosis or treatment, it may evolve to the status of irreversible damage and lead to multiorgan failure and death. 

Based on the cause, distributive shock is the most common type of shock, while hypovolemic and cardiogenic shocks are less common. Obstructive shock is rarer. The most common distributive shock is the septic shock; this type of shock has a high mortality index of 40-50%. 

Cellular hypoxia initiates metabolic and biochemical modifications resulting into acidosis and low regional blood flow that worsens territorial hypoxia. Hypovolemic, obstructive, and cardiogenic shock are associated with reduced cardiac output and oxygen delivery, while distributive shock is defined by decreased peripheral resistance and impaired tissue oxygen utilization. Shock goes through a number of physiological steps, which are reversible in the initial stages and final stages are irreversible, which may lead to multiple organ dysfunction and mortality.

The three stages of shock are: 

  • Pre-shock or Compensated Shock: The body initiates autoregulation processes to ensure tissue perfusion and includes tachycardia, peripheral vasoconstriction, and variations in systemic blood pressure. 
  • Shock: Clinical features that define shock then become manifest when early multiple organ dysfunction syndromes occur in the case of failure of compensation. 
  •  
  • End-Organ Dysfunction: This is the final stage where the organ damage becomes fatal, and this results in multi organ failure and death. 

It is a clinical condition in which there is either tissue hypoxia because of low oxygen delivery or high oxygen demand in tissues. This potentially fatal circulatory dysfunction is characterized by hypotension, with systolic blood pressure below 90 mm Hg, or Mean arterial pressure below 65 mm Hg. It may be caused by many factors and may lead to death if left untreated. It is classified into four main types: are distributive, hypovolemic, cardiogenic, and obstructive. 

Types of Shock: 

  • Distributive Shock: A condition marked by the dilation of blood vessels, which leads to the reduction of pressure in the circulatory system. Subtypes include: 
  • Septic Shock: Due to a serious infection that resulted in organ compromise and an abnormal immune response and involving the use of vasopressors. 
  • Systemic Inflammatory Response Syndrome (SIRS): Bacterial (such as, bacteria and fungi), non-bacterial (for example, pancreatic and burn). 
  • Anaphylactic Shock: Anaphylaxis manifested by cardiovascular compromise and acute hypoxic respiratory failure. 
  • Neurogenic Shock: Secondary to brain or spinal cord injury where the balance of the autonomic nervous system is disturbed. 
  • Endocrine Shock: As a result of certain diseases like adrenal insufficiency etc. 
  • Hypovolemic Shock: Resulting from decrease in intravascular volume, which results in hypotension. Subtypes include: 
  • Hemorrhagic: As a result of other disorders that include gastrointestinal bleeding, traumatic bleeding, or vascular diseases. 
  • Non-Hemorrhagic: As a result of vomiting, diarrhea, kidney infections, burn, or other illnesses such as pancreatitis among others. 
  • Cardiogenic Shock: Resulting from heart related complications; that lowers cardiac output, including: 
  • Cardiomyopathies: For instance, it may be caused by conditions such as acute myocardial infarction or myocarditis. 
  • Arrhythmias: It can lead to both tachyarrhythmias and bradyarrhythmias. 
  • Mechanical Complications: Critically compromised valve function or apparatus failure, such as myocardial rupture. 
  • Obstructive Shock: Pump dysfunction associated with factors outside the heart that impair the ability of ventricles to deliver adequate amounts of blood: 
  • Pulmonary Vascular Causes: Disorders of blood circulation such as pulmonary embolism or severe hypertension. 
  • Mechanical Causes: Conditions that affect the ability of the heart to fill with blood or venous return such as tension pneumothorax or pericardial tamponade. 

Sepsis and septic shock are associated with both short and long-term combined mortalities, and many survivors require further care in long-term acute care hospitals or post-acute care facilities. The mortality of the septic shock stands at a shocking 40 to 50 percent. Cardiogenic shock has a relatively higher mortality ratio estimated at 50-75% although this has been observed to be lowering gradually in the recent past. Hypovolemic and obstructive shock on the other hand, often come with relatively lower mortality rates, and are usually more sensitive to treatment measures. 

Distributive Shock: 

  • Age Group: All ages. 
  • Associated Comorbidities/Activities: Bacterial and viral, inhaled allergens, physical and chemical injury, glandular imbalance. 
  • Acuity: Dramatic; often gets worse quickly. 

Hypovolemic Shock: 

  • Age Group: All populations; however, children and the elderly are at higher risk. 
  • Associated Comorbidities/Activities: Hemorrhagic shock, traumatic shock, septic shock and hemorrhagic shock including paralysis of the gut, blood vomiting. 
  • Acuity: Mild: acute, occurs after massive loss of fluid or blood. 

Cardiogenic Shock: 

  • Age Group: Although it is more frequently diagnosed in the elderly population, it is essential not to exclude alcohol consumption throughout their entire life. 
  • Associated Comorbidities/Activities: Heart diseases, Ischemic heart diseases, Acute coronary syndromes, Myocardial infarction, Cardiac arrhythmias. 
  • Acuity: Sudden; the situation may change immediately in patients with cardiac issues. 

Obstructive Shock: 

  • Age Group: People of all ages including adults, adolescents and even children depending on the cause. 
  • General Appearance: May look anxious, lethargic or confused; skin may be pale and sweaty (hypovolemic/cardiogenic or red and warm (distributive). 
  • Vital Signs: Systolic blood pressure ≤90 mm Hg or mean arterial pressure ≤65 mm Hg, tachycardia, and tachypnoea. 
  • Cardiovascular: He has slow rate, decreased heart tones, and elevated jugular venous pressure in obstructive shock or decreased in hypovolemic shock. 
  • Respiratory: Tachypnea; hypoxemia common, especially if patient has secondary pulmonary disease process. 
  • Abdominal: Presence of distention or reduced bowel movements and sounds. 

These include pulmonary embolism, tension pneumothorax, pericardial tamponade.

Sharp; occurs abruptly because of blockages or problems with the pressure. 

  • Hypovolemic shock 
  • Cardiogenic shock 
  • Disruptive shock 
  • Septic shock 
  • Anaphylactic shock 
  • Neurogenic shock 
  • Endocrine shock 
  • Obstructive shock 
  • Pulmonary vascular causes 
  • Mechanical causes 

General Principles: Determine the type of shock and its source based on the patient’s history, examination, and further testing. ABC’s should be checked and secured. 

Fluid Resuscitation: Give intravenous fluid therapy (for example isotonic fluids such as normal saline or Ringer’s lactate) to replenish intravascular volume and enhance tissue perfusion. The patient should also have their fluid levels checked constantly and periodically changed depending on their reaction to the new fluid levels and presence of clinical signs of fluid overload. 

Vasopressor and Inotropic Support: They are used to raise blood pressure and optimize blood flow to tissues (e. g. norepinephrine, vasopressin, epinephrine). Enhance myocardial contractility in conditions of cardiogenic shock (for example, dobutamine, milrinone). 

Addressing the Underlying Cause 

  • Infectious Shock (Septic Shock): Give broad-spectrum antibiotics and manage the source of the infection (such as draining abscesses). 
  • Hypovolemic Shock: Decrease the amount of fluid that leaks from the system (for example, stop blood loss by performing surgery). 
  • Cardiogenic Shock: Manage the underlying cardiovascular disease (for example, percutaneous coronary intervention for acute myocardial infarction, anti-arrhythmic therapy for arrhythmias). 
  • Obstructive Shock: Treat the cause of the obstruction (e.g. needle thoracocentesis for tension pneumothorax, pericardiocentesis for pericardial tamponade). 

Supportive Therapies 

  • Oxygen Therapy: This will enhance oxygenation in the body as well as reduce arterial hypoxia. 
  • Nutritional Support: Make sure that the patient is fed well, particularly if he or she is in a state of shock for many hours or days. 
  • Monitoring and Reassessment: Monitor cardiovascular and pulmonary status, laboratory values, including arterial blood gases, urine output, and other parameters of perfusion and response to treatment. Always assess the progress of interventions and modify the applied therapy plan accordingly. 

Emergency Medicine

  • Fluid Resuscitation: Give isotonic solution such as normal saline or Ringer’s lactate to help replenishing the blood volume and influx blood flow. To prevent overhydration, monitor the fluid balance of the patient. 
  • Positioning: At times, elevation of legs (Trendelenburg position) facilitates the venous return to the heart; however, this technique is not employed much now because of the inconclusive data on its effectiveness. 
  • Oxygenation: Administer high concentration oxygen to raise the tissue oxygen level and minimize hypoxemia and tissue hypoxia. 
  • Temperature Regulation: When managing hypovolemic or septic shock, use blankets or warming equipment to keep the patient’s temperature warm so that his or her blood vessels circulate well. 
  • Nutritional Support: Super adequate nutritional support through enteral feeding or parenteral nutrition especially in conditions of situs of severe shock. 

Emergency Medicine

  • Normal Saline (0.9% Sodium Chloride): It has sodium at a level of 154 milliequivalents per litre and chloride at a level of also 154 milliequivalents per litre. It is frequently given at the start of hypovolemic and septic shock patients’ resuscitation. It is effective for replenishing the volume and for preservation of blood pressure and possibly, if administered in large volumes or for extended periods, it may cause hyperchloremic metabolic acidosis. 
  • Lactated Ringer’s Solution (LR): It consists of sodium, chloride, potassium, calcium, and lactate. It is transported to the liver where the lactate is converted to bicarbonate to reduce possible acidosis. This tends to be used in most cases of hypovolemic shock particularly in surgeries and trauma cases. This involves providing electrolyte and aid in the elimination of acidosis. 

Emergency Medicine

  • Dobutamine: Initial inotropic drug of choice used in cardiogenic shock and severe heart failure. This drug predominantly exhibits its effect on beta-1 adrenergic receptors hence promoting enhanced force of contractions and rate of heart beats. It has a comparatively notable beta-2 adrenergic actions that result in peripheral vasodilatation. It is useful in enhancing cardiac output in situations where there is reduced myocardial contractility such an acute left heart failure and cardiogenic shock. 
  • Dopamine: It is utilised in cardiogenic shock particularly when there is hypotension associated with reduced tissue perfusion. In cases where doses differ, it resembles the aspect of shock such as hypotension, and optionally, low cardiac output. 
  • Milrinone: It is given in those patients who present with cardiogenic shock especially when there is acute decompensated heart failure. A phosphodiesterase-3 inhibitor that raises intracellular cAMP thereby improving cardiac contractility and dilating the blood vessels. 

Emergency Medicine

  • Piperacillin-Tazobactam: A combination antibiotic, derived from the broad-spectrum penicillin group, specifically piperacillin and the beta-lactamase inhibitor called tazobactam. It offers general antibacterial activity against various bacterial species, including both the gram-positive and the gram-negative class. It is used often in the initial empirical therapy in septic shock to include a range of pathogens that may be causing the syndrome. It is used when the causative bacteria are not known and but there is requirement of wide spectrum coverage.  
  • Vancomycin: It is a glycopeptide antibiotic with high bactericidal activity against Gram-positive bacteria, particularly against methicillin-resistant Staphylococcus aureus (MRSA). This class of antibiotics is particularly effective against Gram-positive bacteria, particularly various strains that are resistant to other drugs such as Methicillin-Resistant Staphylococcus aureus (MRSA). It is commonly prescribed in the situations, where either MRSA or other resistant Gram-positive bacteria are known to be present. 

Emergency Medicine

Fluid Resuscitation: In shock, especially hypovolemic shock, the general management strategy involves the administration of fluids through a vascular access route. Crystalloids such as normal saline, lactated Ringer’s solution are often employed while colloids like hydroxyethyl starch may be administered in certain situations. 

Vasopressor Therapy: For instance, there is utilization of drugs such as Norepinephrine, Epinephrine, and dopamine to help raising blood pressure and hence enhance perfusion. These are particularly relevant in septic shock or cardiogenic shocks where there is inadequate adequate fluid load. 

Inotropic Agents: The treatments for cardiogenic shock include drugs like dobutamine or milrinone to enhance the strength of heart contraction or cardiac output respectively. 

Central Venous Pressure Monitoring: 

  • Central Line Insertion: The placement of a central venous catheter enables easy determination of the central venous pressure and also serves as an access point for fluid and medication administration. This is helpful in managing the fluid administration and in the assessment of the patient’s hemodynamic state. 
  • Arterial Line Insertion: An arterial catheter can also enable constant blood pressure measurement and the possibility to obtain frequent blood gases. It is especially useful for the administration of massive shock. 
  • Endotracheal Intubation and Mechanical Ventilation: When shock is linked with respiratory failure or the compromised airway, endotracheal intubation and mechanical ventilation might be necessary because of impaired ventilation and oxygenation. 
  • Surgical Interventions: Surgical intervention is often required in cases of traumatic shock, intraabdominal hemorrhage, or major infection such as sepsis and may be aimed at managing the underlying cause of the shock, for example bleeding or abscess aspiration. 

Emergency Medicine

  • Initial Assessment and Stabilization: Perform a primary and secondary assessment to address the patient’s airway, breathing, circulation. Start the process of quick fluid replacement and give oxygen to the patient.
  • Fluid Resuscitation: Give crystalloids (and colloids as required) to maintain intravascular volume. Supervise response and adapt corresponding interventions of fluid therapy appropriately. 
  • Identifying and Treating the Cause: Identify the possible cause of shock like infection, hemorrhage and initiate suitable treatment like antibiotics, vasopressors respectively. 
  • Supportive Care and Monitoring: Give care to support organ function, check vital signs, and adjust the treatment plan if required.
  • Reassessment and Ongoing Management: It is necessary to evaluate the patient’s condition and effectiveness of the implemented therapy periodically. 

Free CME credits

Both our subscription plans include Free CME/CPD AMA PRA Category 1 credits.

Digital Certificate PDF

On course completion, you will receive a full-sized presentation quality digital certificate.

medtigo Simulation

A dynamic medical simulation platform designed to train healthcare professionals and students to effectively run code situations through an immersive hands-on experience in a live, interactive 3D environment.

medtigo Points

medtigo points is our unique point redemption system created to award users for interacting on our site. These points can be redeemed for special discounts on the medtigo marketplace as well as towards the membership cost itself.
 
  • Registration with medtigo = 10 points
  • 1 visit to medtigo’s website = 1 point
  • Interacting with medtigo posts (through comments/clinical cases etc.) = 5 points
  • Attempting a game = 1 point
  • Community Forum post/reply = 5 points

    *Redemption of points can occur only through the medtigo marketplace, courses, or simulation system. Money will not be credited to your bank account. 10 points = $1.

All Your Certificates in One Place

When you have your licenses, certificates and CMEs in one place, it's easier to track your career growth. You can easily share these with hospitals as well, using your medtigo app.

Our Certificate Courses